ClinicalTrialsFinder
RecruitingNot ApplicableNCT07062172

Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer

Sponsor

University of California, Irvine

Enrollment

1,753 participants

Start Date

May 8, 2025

Study Type

INTERVENTIONAL

Conditions

Lung CancerDriver Mutation

Summary

This is a single-armed screening research study which screens immediate family member of lung cancer patients with a driver mutation to see if lung cancer can be inherited and whether researchers can find lung cancer early. Immediate family members of lung cancer patients will be 40-80 years old and screened using a low dose CT scan.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria14

  • Cohort A:
  • Current diagnosis of lung cancer with a driver mutation.
  • Known driver mutation (e.g. via NGS, PCR, IHC, FISH, RT-PCR etc.)
  • Able and willing to give informed consent.
  • Able and willing to complete the screening questionnaire.
  • Cohort A:
  • Age 40 - 80.
  • Must have a first degree relative (mother, father, sibling, biological child) eligible for Cohort A. Note: Multiple first degree relatives of a Cohort A eligible participant may be approached for participation into the trial.
  • Smoked \< 20 pack years; a. Pack years = numbers of packs per day × number of years smoked; b. One pack year is the equivalent of smoking an average of 20 cigarettes (1 pack) per day for a year.
  • Be able to undergo a low dose chest CT scan.
  • If an upper respiratory infection (pneumonia, COVID19, flu, etc.) occurred in the last 3 months, this infection must have resolved by time of enrollment.
  • Able and willing to provide informed consent.
  • Able and willing to comply with the protocol requirements
  • Cohort B:

Exclusion Criteria8

  • Cohort B:
  • Previous history of lung cancers.
  • Symptoms suggestive of presence of current lung cancer, including (but not limited to): unexplained weight loss of over 15 pounds within the last 12 months or unexplained hemoptysis.
  • Pregnant at time of enrollment.
  • History of any type of cancer within 5 years, with the exception of in situ carcinomas and non-melanoma skin cancers (if excised).
  • Current smoker.
  • Smoked ≥ 20 pack years.
  • Had a chest CT scan within 1 year of study entry.

Interventions

DIAGNOSTIC_TESTLow Dose CT Scan

Completed once after screening and eligibility is confirmed.

Locations(1)

Chao Family Comprehensive Cancer Center University of California, Irvine

Orange, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07062172

Related Trials

Virtual Agent Feasibility in Oncology Patients (NTT Data)

NCT066820131 location

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

NCT046786483 locations

Study of Novel Treatment Combinations in Patients With Lung Cancer

NCT05633667100 locations

Empathic Communication Skills (ECS) Training

NCT0545684112 locations

Rhomboid Intercostal Block vs Erector Spinae Block

NCT070406181 location